Which Pharma Firm Increases US Prices The Most?
Executive Summary
Transparency reports from companies aim to change conversation from prices to discounts, but also invite comparisons. Lilly, for example, saw a higher average list price increase in 2016 than Merck and Janssen, but its net prices grew by less than the others.
You may also be interested in...
Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline
Price transparency reports from the big pharmas also show continued increases in price concessions in 2017, but a slow-down in list price increases.
Lilly's Prices After Concessions Rise 6% In 2017, While Merck's Net Prices Decline
Price transparency reports from the big pharmas also show continued increases in price concessions in 2017, but a slow-down in list price increases.
Just Trust Me: Most Firms Unwilling To Publicly Pledge Pricing Restraint
Public Citizen reached out to the 28 largest biopharma manufacturers after Allergan announced its pricing pledge to see who else might follow suit. The answer was, not many.